1-6 of 6
Wenjun Wu, M.Med
Close
Sort by
Journal Articles

The Choice Of Regimens Based On Bortezomib For Patients With Newly Diagnosed Multiple Myeloma

Li Yang, M.Med, Jingsong He, MD, PhD, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Weiyan Zheng, Ph.D., Guoqing Wei, Ph.D.;M.D., Wenjun Wu, M.Med, Xiujin Ye, M.D. Ph.D., Jimin Shi, M.D., Wanzhuo Xie, M.D. Ph.D., Li Li, M.Med, Jie Zhang, M.Med, Weijia Huang, M.Med, Yi Zhao, PhD, He Huang, MD, PhD., Xuejin Zhang, M.D. Ph.D., Jiaping Fu, M.D. Ph.D., Zhen Cai, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1990.
https://doi.org/10.1182/blood.V122.21.1990.1990
Published: 2013
Journal Articles

Homoharringtonine In Combination With Cytarabine and Etoposide For Induction Therapy In Patients With De Novo Acute Myelogenous Leukemia

Jingsong He, MD, PhD, Li Li, M.Med, Jingjing Zhu, Yi Zhao, PhD, Wenjun Wu, M.Med, Yanlong Zheng, Gaofeng Zheng, M.Med, Weiyan Zheng, M.D., Xiaoli Zhu, He Huang, MD, PhD., Xiujin Ye, M.D. Ph.D.
Journal: Blood
Blood (2013) 122 (21): 5006.
https://doi.org/10.1182/blood.V122.21.5006.5006
Published: 2013
Journal Articles

The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma

Yi Li, M.Med, Wenjun Wu, M.Med, Jingsong He, MD, PhD, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Fuming Zi, M.Med, Li Yang, M.Med, Cai Wu, M.Med, Donghua He, PhD, Yi Zhao, PhD, Yang Yang, PhD, Lijuan Wang, PhD, Xiujin Ye, M.D. Ph.D., He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3082.
https://doi.org/10.1182/blood.V122.21.3082.3082
Published: 2013
Journal Articles

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Fuming Zi, M.Med, Jingsong He, MD, PhD, Donghua He, PhD, Yi Li, M.Med, Li Yang, M.Med, Lijuan Wang, PhD, Yang Yang, PhD, Yi Zhao, PhD, Wenjun Wu, M.Med, He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3083.
https://doi.org/10.1182/blood.V122.21.3083.3083
Published: 2013
Journal Articles

Clinical Significance of Serum Free Light Chain Test in the First Onset of Multiple Myeloma

Pan Hong, M.Med, Xiaojian Meng, Ph.D, Jingsong He, M.D. Ph.D., Wenjun Wu, M.Med, Yi Li, M.Med, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Yi Zhao, Ph.D, Donghua He, MD, PhD, Jimin Shi, M.D. Ph.D., Wanzhuo Xie, M.D. Ph.D., Jie Zhang, M.Med, Xiujin Ye, M.D. Ph.D., He Huang, M.D.; Ph.D., Zhen Cai, M.D. Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4999.
https://doi.org/10.1182/blood.V120.21.4999.4999
Published: 2012
Journal Articles

Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients

Jingsong He, M.D., Ph.D., Li Yang, M.Med, Dian Jin, M.Med, Xuanru Lin, M.Med, Qianqian Yang, M.Med, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Weiyan Zheng, Ph.D., Guoqing Wei, Ph.D., Wenjun Wu, M.Med, Xiujin Ye, M.D., Ph.D., Jimin Shi, M.D., Ph.D., Wanzhuo Xie, M.D., Ph.D., Jie Zhang, M.Med, Maofang Lin, M. D, Ph.D, He Huang, M.D., Ph.D., Zhen Cai, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 5048.
https://doi.org/10.1182/blood.V120.21.5048.5048
Published: 2012